STEPHANIE EAST: Open Payments
NPI 1487260832 · LYNCHBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$676 in 35 payments from 9 companies in 2025. Trend: 2023 $1,595 · 2024 $1,242 · 2025 $676
Food & beverage: $676
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $301 |
| Otsuka America Pharmaceutical, Inc. | 8 | $143 |
| Supernus Pharmaceuticals, Inc. | 1 | $78 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $47 |
| Alkermes, Inc. | 1 | $29 |
| Indivior Inc. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Corium, LLC | 1 | $15 |
Products named: CAPLYTA, REXULTI, Qelbree, TRINTELLIX, ARISTADA, SUBLOCADE, COBENFY, Auvelity.
Industry payments across VA — which companies pay providers there.
